[1]李怡敏,袁琳,杨生永,等.干扰素诱导肝癌细胞ADAR1的表达模式及HBV复制抑制[J].第三军医大学学报,2019,41(14):1336-1342.
 LI Yimin,YUAN Lin,YANG Shengyong,et al.Effect of interferons on expression of adenosine deaminase acting on RNA 1 and hepatitis B virus replication in human hepatocellular carcinoma cells in vitro[J].J Third Mil Med Univ,2019,41(14):1336-1342.
点击复制

干扰素诱导肝癌细胞ADAR1的表达模式及HBV复制抑制
(/HTML )
分享到:

《第三军医大学学报》[ISSN:1000-5404/CN:51-1095/R]

卷:
41卷
期数:
2019年第14期
页码:
1336-1342
栏目:
基础医学
出版日期:
2019-07-30

文章信息/Info

Title:
Effect of interferons on expression of adenosine deaminase acting on RNA 1 and hepatitis B virus replication in human hepatocellular carcinoma cells in vitro
作者:
李怡敏袁琳杨生永胡源胡接力黄爱龙涂增
重庆医科大学:感染性疾病分子生物学教育部重点实验室,基础医学院病原生物学教研室,分子医学与肿瘤研究中心
Author(s):
LI Yimin YUAN Lin YANG Shengyong HU Yuan HU Jieli HUANG Ailong TU Zeng 

Key Laboratory of Molecular Biology on Infectious Diseases of Ministry of Education; Department of Pathogen Biology, Molecular Medicine and Tumor Research Center, College of Basic Medical Sciences, Chongqing Medical University, Chongqing, 400016, China

关键词:
干扰素ADAR1肝癌细胞乙型肝炎病毒
Keywords:
interferon adenosine deaminase acting on RNA 1 hepatocellular carcinoma cells hepatitis B virus
分类号:
R735.7;R966;R977.6
文献标志码:
A
摘要:

目的 探讨Ⅰ型干扰素(IFN-α、IFN-β)和Ⅱ型干扰素(IFN-γ)在肝癌细胞中诱导ADAR1(P110和P150)的表达模式及对HBV复制的作用。方法 不同浓度IFN-α(0、200、500、1 000、2 000 U/mL)、IFN-β(0、200、1 000 U/mL)和IFN-γ(0、200、1 000 U/mL)分别处理肝癌细胞(Huh7和HepG2),Western blot和RT-qPCR检测肝癌细胞中IFN作用后ADAR1的表达变化;Huh7细胞瞬时转染HBV复制型质粒,IFN-α作用后,Southern blot分析HBV DNA复制中间体水平。结果 Ⅰ型IFN(IFN-α、IFN-β)作用Huh7和HepG2细胞后,ADAR1 P110蛋白水平增加(P<0.05),同时ADAR1 P150表达水平明显增高(P<0.01),且ADAR1 P150的表达呈现IFN浓度依赖性;Ⅱ型IFN(IFN-γ)作用Huh7和HepG2细胞后,ADAR1 P110和P150蛋白表达水平没有发生明显变化。IFN-α明显抑制Huh7细胞中HBV复制(P<0.05),与浓度梯度呈负相关。结论 Ⅰ型IFN可诱导肝癌细胞中ADAR1 P150表达,IFN-α抑制Huh7细胞中HBV复制,其作用可能与ADAR1相关。

Abstract:

Objective To investigate the effect of type Ⅰ interferons (IFN-α and IFN-β) and type Ⅱ interferon (IFN-γ) on the expression of adenosine deaminase acting on RNA 1 (ADAR1, P110 and P150) and hepatitis B virus (HBV) replication in hepatocellular carcinoma (HCC) cells. Methods Western blotting and qRT-PCR were used to detect the expression of ADAR1 in human HCC cell lines HepG2 and Huh7 following treatment with different concentrations of IFN-α, IFN-β or IFN-γ. Southern blotting was employed to detect the changes in HBV DNA level in response to IFN-α treatment in Huh7 and HepG2 cells transfected with HBV replication plasmids. ResultsIn Huh7 and HepG2 cells, treatments with IFN-α and IFN-β significantly increased the protein expression of ADAR1 P150 in a time- and dose-dependent manner (P<0.01) and also obviously augmented the protein level of ADAR1 P110; IFN-γ did not significantly affected the expression of either ADAR1 P110 or ADAR1 P150. IFN-α treatment dose-dependently inhibited HBV DNA replication in Huh7 cells (P<0.05). Conclusion Type Ⅰ interferons time- and dose-dependently increase the expression of ADAR1 in Huh7 and HepG2 cells, suggesting a possible role of ADAR1 in mediating the anti-HBV effect of IFN-α.

更新日期/Last Update: 2019-07-22